Literature DB >> 26835305

Treatment of Hodgkin's lymphoma in childhood and adolescence without radiotherapy.

Wolfgang Dörffel1, Alexander Claviez1, Heike Lüders1, Ursula Rühl1.   

Abstract

Entities:  

Year:  2013        PMID： 26835305      PMCID： PMC4728929          DOI： 10.3978/j.issn.2224-4336.2013.07.02

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


× No keyword cloud information.
  10 in total

1.  Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua.

Authors:  F Baez; E Ocampo; V Conter; A Flores; T Gutierrez; A Malta; C Pacheco; R Palacios; A Biondi; L Riva; A Sala; D Silvestri; F Cavalli; C Sessa; M Casanova; G Masera
Journal:  Ann Oncol       Date:  1997-03       Impact factor: 32.976

2.  Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group.

Authors:  Suzanne L Wolden; Lu Chen; Kara M Kelly; Philip Herzog; Gerald S Gilchrist; John Thomson; Richard Sposto; Marshall E Kadin; Raymond J Hutchinson; James Nachman
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

3.  Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.

Authors:  Günther Schellong; Wolfgang Dörffel; Alexander Claviez; Dieter Körholz; Georg Mann; Hans-G Scheel-Walter; Jos P M Bökkerink; Marianne Riepenhausen; Heike Lüders; Richard Pötter; Ursula Rühl
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

4.  Hodgkin's disease in children. A ten-year experience in South Africa.

Authors:  P Jacobs; H S King; C Karabus; P Hartley; D Werner
Journal:  Cancer       Date:  1984-01-15       Impact factor: 6.860

5.  Childhood Hodgkin's disease in Uganda: a ten year experience.

Authors:  C L Olweny; E Katongole-Mbidde; C Kiire; S K Lwanga; I Magrath; J L Ziegler
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

6.  Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.

Authors:  Günther Schellong; Marianne Riepenhausen; Christian Bruch; Stefan Kotthoff; Johannes Vogt; Tobias Bölling; Karin Dieckmann; Richard Pötter; Achim Heinecke; Jürgen Brämswig; Wolfgang Dörffel
Journal:  Pediatr Blood Cancer       Date:  2010-12-01       Impact factor: 3.167

7.  Hodgkin's disease in Indian children: outcome with chemotherapy alone.

Authors:  Laxman S Arya; Veronique Dinand; Vasantha Thavaraj; Sameer Bakhshi; Ramesh Dawar; Goura K Rath; Rajvir Singh; Tribhuvan S Vats
Journal:  Pediatr Blood Cancer       Date:  2006-01       Impact factor: 3.167

8.  Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Authors:  James B Nachman; Richard Sposto; Philip Herzog; Gerald S Gilchrist; Suzanne L Wolden; John Thomson; Marshall E Kadin; Paul Pattengale; P Charlton Davis; Raymond J Hutchinson; Keith White
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

9.  Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.

Authors:  Friederike G A J Hakvoort-Cammel; Saskia Buitendijk; Marry van den Heuvel-Eibrink; Karel Hählen
Journal:  Pediatr Blood Cancer       Date:  2004-07       Impact factor: 3.167

10.  Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.

Authors:  Wolfgang Dörffel; Ursula Rühl; Heike Lüders; Alexander Claviez; Marion Albrecht; Jos Bökkerink; Harald Holte; Jonas Karlen; Georg Mann; Heinz Marciniak; Felix Niggli; Kjeld Schmiegelow; Ernst-Wilhelm Schwarze; Richard Pötter; Lutz Wickmann; Günther Schellong
Journal:  J Clin Oncol       Date:  2013-03-18       Impact factor: 44.544
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.